Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Kids may be more likely to get the new ‘Cicada’ variant of Covid-19, scientists say. Here’s what to know about BA.3.2 - 2The most effective method to Explore Moral Situations in Brain research with Your Certification
- 3UAE used military bases in Red Sea region to aid Israel's war against Hamas, leaks reveal
- 4Top 20 Style Brands for Pioneers
- 5Israel's fractured opposition hands Netanyahu a full term
- Rubble, mud and hair: How to rebuild a home in Gaza
- NASA Artemis II tracker: Where is the Orion now and when will it reach the moon?
- Novo Nordisk slashes prices of popular weight loss and diabetes drugs
- The most effective method to Use an Internet Showcasing Degree for Advanced Predominance
- Jill Hennessy was a '90s TV staple. Now she's in her fearless era.
- 5 Great Home Remodel Administrations With Green Arrangements In 2024
- Step by step instructions to Figure out the Natural Effect of 5G Pinnacles
- From Novice to Master: Dominating a Side interest
- Anger as German family business group opens talks with far-right AfD
